These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2506570)

  • 1. Mediators of acute lung injury in endotoxaemia.
    Parratt JR; Pacitti N; Rodger IW
    Prog Clin Biol Res; 1989; 308():357-69. PubMed ID: 2506570
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostaglandins, cyclo-oxygenase inhibitors, and thromboxane synthetase inhibitors in the pathogenesis of multiple systems organ failure.
    Petrak RA; Balk RA; Bone RC
    Crit Care Clin; 1989 Apr; 5(2):303-14. PubMed ID: 2495847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary dysfunction caused by diffuse lung inflammation. Roles of metabolites of arachidonic acid.
    Brigham KL
    Prog Biochem Pharmacol; 1985; 20():26-37. PubMed ID: 3921978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandins and hemostasis: an overview.
    Stuart MJ
    Adv Pediatr; 1983; 30():321-64. PubMed ID: 6231843
    [No Abstract]   [Full Text] [Related]  

  • 5. Arachidonic acid metabolites as mediators of lung injury during intravascular complement activation.
    Gee MH; Tahamont MV; Perkowski SZ; Flynn JT
    Prog Biochem Pharmacol; 1985; 20():108-19. PubMed ID: 3921977
    [No Abstract]   [Full Text] [Related]  

  • 6. The pathophysiological role of PAF in anaphylactic lung reaction in the guinea pig and in endotoxin shock evidenced by the specific PAF-antagonist WEB 2086.
    Heuer H; Casals-Stenzel J
    Prog Clin Biol Res; 1989; 308():925-30. PubMed ID: 2675077
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipid mediators of the allergic reaction.
    Chilton FH; Lichtenstein LM
    Chem Immunol; 1990; 49():173-205. PubMed ID: 2112394
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of arachidonic acid metabolism in endotoxic horses: comparison of flunixin meglumine, phenylbutazone, and a selective thromboxane synthetase inhibitor.
    Moore JN; Hardee MM; Hardee GE
    Am J Vet Res; 1986 Jan; 47(1):110-3. PubMed ID: 3080926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiopulmonary function as related to thromboxane A2 synthesis in experimental septic shock.
    Schützer KM; Lindholm E; Haglund U; Falk A
    Circ Shock; 1988 Sep; 26(1):27-40. PubMed ID: 3056632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
    Tobias LD; Hamilton JG
    Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemical mediators].
    Okiji T; Murota S
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(2):171-84. PubMed ID: 1901997
    [No Abstract]   [Full Text] [Related]  

  • 12. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological manipulation of inflammation in rabbit hydronephrosis: effects of a combined cyclooxygenase/lipoxygenase inhibitor ethoxyquin, a thromboxane synthase inhibitor RS-5186 and a PAF antagonist L-659,989.
    Spaethe SM; Hsueh W; Needleman P
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1308-16. PubMed ID: 2539462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Septicemia and lung injury.
    Brigham KL; Begley CJ; Bernard GR; Hutchison AA; Loyd JE; Lucht WD; Meyrick B; Newman JH; Niedermeyer ME; Ogletree ML
    Clin Lab Med; 1983 Dec; 3(4):719-44. PubMed ID: 6197226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enzyme inhibitors and receptor antagonists in the arachidonic cascade].
    Arai Y; Kawamura M
    Nihon Rinsho; 1990 Jun; 48(6):1120-8. PubMed ID: 2166837
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bioactive derivatives of arachidonic acid in the human neutrophilic granulocyte. The icosanoid "alphabet" (II)].
    Dragomirescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1988; 33(1):1-14. PubMed ID: 2848308
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of lung injury by platelet-activating factor antagonism in nonhypotensive porcine endotoxemia.
    Abu-Zidan FM; Walther S; Lennquist S
    Circ Shock; 1994 Nov; 44(3):148-53. PubMed ID: 7600638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of platelet-activating factor (PAF) in shock, sepsis and adult respiratory distress syndrome (ARDS).
    Braquet P; Hosford D
    Prog Clin Biol Res; 1989; 308():425-39. PubMed ID: 2675060
    [No Abstract]   [Full Text] [Related]  

  • 19. Arachidonate cyclooxygenase metabolites as mediators of complement-initiated lung injury.
    Gee MH; Perkowski SZ; Tahamont MV; Flynn JT
    Fed Proc; 1985 Jan; 44(1 Pt 1):46-52. PubMed ID: 3917940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor in septic shock.
    Koltai M; Hosford D; Braquet PG
    New Horiz; 1993 Feb; 1(1):87-95. PubMed ID: 7922397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.